{"name":"Atamyo Therapeutics","slug":"atamyo-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxPVE83TVlMM3NJQTJBSkx1T0hjQjRtUGRuQ0FIX0JjNWpTeTNHUTFpMW5OVTM1cHpwTFRJQnFFV0pwcVdEbXFyQlRrUUJ3MC1iTWRKOC1nNmZFcnRqT0FkTUlBd1VBYVd1Z3hRdGI0Ql8tejFKN2wwVkNaTUNELXR4Yi1Vc3BRSjVrOG9FQTJOU3RHUk92eVNfbFVvaGhWaEtlbm9mRnd1NEhmcnhSY2J3a3h1TFlRSzVyMVRxS1NZcUt1SDhoZnlidnotVVNuNlZ6Ml9XckpRb1lqUFBldlpKN1JEZHFWYWhnTHBHd0o4VGdYaE8wMVcydEt4bjhhNW9LUFV6V1FEczdKRWQzeGlnbjQ0WWpuNG9zZXpDaXQtaXpNeDJidHRzOUNvQXBVUTZxNHZOeU1vcUtGMTVkV1E?oc=5","date":"2026-03-09","type":"trial","source":"BioSpace","summary":"Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinical Trial Targeting LGMD-R5 Limb-girdle Muscular Dystrophy - BioSpace","headline":"Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNS1pDeWRxNkpraHIwRWx4aXMxenVtMVhJWHNORXF2ZkN1bHBRM3dGOThDVE1PWFNkNVA3X01ZSXpHelYtYVBIYTRFR1I5WU5kOV9CcDNnVmd3TkdpWl9aY2JYRHc3SmliZTFDRXk5UldYNzlEVDM5dXdLb3FpOTgwOUxIQ1Q2SDh4ZTgxbXEzUElTbHpHNDhHcG9NVFViMkg5ejN4RkY2eVBSUQ?oc=5","date":"2025-10-28","type":"trial","source":"The Business Journals","summary":"BridgeBio's stock soars after stunning early data against a deadly rare disease - The Business Journals","headline":"BridgeBio's stock soars after stunning early data against a deadly rare disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNX01xMFpkVTMtR3lnSzRLQ1A5Sy1ndDI5RlQtbmlrVFRXVWhzN2NMWG9EUTRlTE90RkVqUzY4d2tFM0twa1RoenZPSXpJOHF3OF9EWjlFYVBMWDdKb1BwX1N0YllqNU9uNmN1SmdsUU4xaElGcnZHTWQxV2RzMjFtbk9YV012SFg0QWxiWldqQ081cmF3d054MkU4cGE1VnRNcHBrRmpiWWdXMTRVUjlHZGJEcEo5Z0xZM2I3X25HanE5S3BmMFdJN3BrZkpaM3dmSTFrdjFIX3gtNlNIZHByOXdpWUxBYjltZXl6N0FlbEVMYUZKODduNUhLRWJHNHllWDdQUXBrYTRyNS1CenJLcUJB?oc=5","date":"2024-11-12","type":"regulatory","source":"Business Wire","summary":"IND for ATA-200, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2C/R5 (LGMD2C/R5), cleared to proceed by FDA - Business Wire","headline":"IND for ATA-200, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2C/R5 (LGMD2C/R5), cleared to p","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQTmdzLTBfcHY0X3pBNmtBYS1WalUtazFUWnQ1emR3TzlGMG5NSlRUSXJ4bEFZcmpiTUZ6UmlwWEl1QTJ2V2NYYzdreDBQX2N3RHhpczFJWnhCbUlPci05WUZvcUlJOTdzemRwdHBrOEV3Y2J4bk9HUlJWdlBNek9jRWE4YnZYb0tuU1ZWUWs1YS0wTS03UFVLZVR0a0J3ZmNjUHVMVHJXNA?oc=5","date":"2024-09-30","type":"pipeline","source":"CGTLive®","summary":"Atamyo Therapeutics Hits Milestones for Limb-Girdle Muscular Dystrophy Programs - CGTLive®","headline":"Atamyo Therapeutics Hits Milestones for Limb-Girdle Muscular Dystrophy Programs - CGTLive®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPWUlNZHZGY0Y2aTFLYWhWNUVVWFN5WHgwaGEyUXlrNHN1VE9DUXRmLWdMMlp1QzR5U0piZFB2cXBSWG5GZXpTVTRaQkJCWU1naFZ3ZkFhdUZpaEJRcnIzUVUxS3VIdlR1TEpiWXVOdGRiMWhiTlpudmdjSVpHVFIxV2pOLU9BalBKemFZQ1UyTkxxbGg5VHFFV01vYmthb2pB?oc=5","date":"2024-09-10","type":"trial","source":"Muscular Dystrophy News","summary":"Atamyo, Dion Foundation partner to expand LGMD study into US - Muscular Dystrophy News","headline":"Atamyo, Dion Foundation partner to expand LGMD study into US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wJBVV95cUxOUHBSbnJraEhKOGZlMnRlOWNSNHlsNm9XYUs4czBpbWxBLXJlVnNRRkw5Z3lLS2FkSGNoajJhaHpWWU1CSGNpUFVBdEhIcjhBcmNzbHJJdUlrcm51bXlaLXhncGdBc0pnM3hTVU9yNkV4QXBlVU5zY2dTZlRkZU1SX2kwRE4wU0FYcGRIV2otbkN1TFl0QjQyTUx1Z3FCVUdzOWZvLVNKSHBYSlNXZnVSTm1nTkoxMldUVDNsQ0lZSHFDekItaGxlcVNUQ0hBWG5YRHVwckY5Tk5uczdITDExVGpVUUgxNU0xNlRVN0lZa2dhclJoYVdFNnRMOVNodHZRNGxVbV80M21NMVlXZExNbG9nNHNJT1E5dk5NZzRJckdBWElRODl1RFUwcXNXODY2bHlMbkNwazd4M0hHOHllblJhRkJGQXBBVkFJT2dCRFhnbVFNVUJleHdkQVdGcjg?oc=5","date":"2024-09-04","type":"trial","source":"Business Wire","summary":"The Dion Foundation and Atamyo Therapeutics Announce a Partnership to Expand into the US Atamyo’s Clinical Trial of ATA-200 Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2C/R5 - Business W","headline":"The Dion Foundation and Atamyo Therapeutics Announce a Partnership to Expand into the US Atamyo’s Clinical Trial of ATA-","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPX3pMMzRxdllZSzBCWFo0cUl6ckxxWXo3WVN0LUMxaGI1djEwY0MwN0RkS0Y3Wks5ZHFoamZ6YTZ6U0syN0xVN3NobGc1c1M2c1JIVUJxRjNKR2VMQWJ0OFBrcDVKajFDQ0ZyYmZKOWpHdFM2RnRpdU1ScWh3eGxSNVZRWXVaV2syZTFtRFZ3UQ?oc=5","date":"2024-03-27","type":"trial","source":"Clinical Trials Arena","summary":"Atamyo obtains clearance for muscular dystrophy gene therapy trial in Europe - Clinical Trials Arena","headline":"Atamyo obtains clearance for muscular dystrophy gene therapy trial in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOOWt6My1PZjdidTMxbW12bHJNdC15MmpIbllOTC1aWkNtYS1BNEpzbzFUQjRhUDlwR3UxQjJoOVl0UXJpcXZ4WHBrYXg4aUdUWGctNUtaUzY0RlFhWVlkWHVXeXNFLTVSWUdnV3ljX0JvbFE0U1FOOG9pdzJHT0JUSFRKczYzTGJndkMtZ003ZXV2OGJrWnV0RnU3aVR2TXFxdFJ3N3k2djBTeFRCb1E?oc=5","date":"2024-03-27","type":"pipeline","source":"BioWorld News","summary":"Atamyo’s gene therapy for LGMD2C/R5 cleared to enter clinic in Europe - BioWorld News","headline":"Atamyo’s gene therapy for LGMD2C/R5 cleared to enter clinic in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPT3RaTlRHei1pR1Q2clcwUFhfOTFsWWlzbW9rLXh3MmlYNlJRSnFCeGx1RVJlX0tsakN4cHF3SGtvQnpFNktzWE00YmNGblZ3MTdqdmdzVGdkSGRKNjBiRFJZS0ZJWDBhQVpiWWdXRlhJSWZ1Qkw5OUZ4NUJEdjJVUm96eDlKWXpIZXNoNHJlRHg0YmFNNmt3cVVsRFEwbFFwdktoQUJnai14eF94eG9IbmppMHBPQ3VpZ0tWV2NqS0pndjZMN2c?oc=5","date":"2023-10-30","type":"pipeline","source":"European Pharmaceutical Review","summary":"Gene therapy for rare muscular dystrophy presents preliminary promise - European Pharmaceutical Review","headline":"Gene therapy for rare muscular dystrophy presents preliminary promise","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}